PCRX logo
PCRX NASDAQ US

Pacira BioSciences, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Feb 2011
$22.70
▼ $-0.09 (-0.39%)
Vol 750K
12
Quality Score
ok
Deep Check
2/5 ok
Mkt Cap
$1.1B
P/E
51.9
ROE
2.8%
Margin
3.0%
D/E
51.80
Beta
0.25
52W
$18–$28

Wall Street Consensus

13 analysts · Apr 2026
3
Strong Buy
6
Buy
3
Hold
1
Sell
0
Strong Sell
69.2%
Buy Rating

Price Chart

Similar Stocks

COLL
Collegium Pharmaceutical Inc
P/E 25.0
$1.5B
XERS
Xeris Biopharma Holdings Inc
$1.3B
AMPH
Amphastar Pharmaceuticals Inc
P/E 11.0
$1.2B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
OMER
Omeros Corp
$1.2B
SGP
SpyGlass Pharma Inc
RLMD
Relmada Therapeutics Inc
$354.2M

Earnings

Beat rate: 75.0%
Next Report May 06, 2026
EPS Estimate: $0.59
Quarter EPS Est EPS Act Surprise
Mar 2026 $0.59 — —
Dec 2025 $0.92 $0.57 $-0.35
Sep 2025 $0.66 $0.70 +$0.04
Jun 2025 $0.72 $0.74 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -16.5% -16.5% -16.5% -16.5% 2.8% 2.8%
P/E (TTM) — — — — 48.26 51.94
Net Margin -2.7% -18.1% -18.1% -18.1% 3.0% 3.0%
Gross Margin 77.4% 78.2% 78.2% 78.2% 79.2% 79.2%
D/E Ratio 76.61 76.61 76.61 76.61 51.80 51.80
Current Ratio 2.38 2.38 2.38 2.38 5.26 5.26

Key Ratios

ROA (TTM)
1.4%
P/S (TTM)
1.55
P/B
1.1
EPS (TTM)
$0.47
CF/Share
$1.93
Rev Growth 3Y
+9.0%
52W High
$27.64
52W Low
$18.17
$18.17 52-Week Range $27.64

How does PCRX compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

PCRX AARD ACB ACRS ADIL

PCRX valuation vs Pharmaceuticals peers

P/E ratio
51.9
▲ 132% above peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
1.6
▼ 69% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
1.1
▼ 47% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

PCRX profitability vs Pharmaceuticals peers

ROE
2.8%
▲ 105% above peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
3.0%
▲ 106% above peers (-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
79.2%
▲ 16% above peers (68.3%)
vs Peers
vs Industry
Weak
ROA
1.4%
▲ 104% above peers (-37.4%)
vs Peers
vs Industry
Top tier

PCRX financial health vs Pharmaceuticals peers

D/E ratio
51.8
▲ 3264% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
5.3
▲ 56% above peers (3.4)
vs Peers
vs Industry
Below avg
Beta
0.3
▼ 73% below peers (0.9)
vs Peers
vs Industry
More volatile

PCRX fundamentals radar

PCRX Peer median Industry

PCRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

PCRX vs peers: key metrics

Latest News

No related news yet